clinical laboratory screening of bleeding disorders (e.g. platelet dysfunction, dysfibrinogenaemias, disseminated intravascular coagulation and hyperfibrinolysis) (Hartert, 1981 (Hartert, , 1982 but to our knowledge has not been evaluated as a risk marker for incident CHD in population-based prospective studies.
We therefore evaluated the association of four RTG indices with incident CHD, conventional CHD risk factors, and other haematological variables in the Caerphilly Prospective Heart Disease Study. The objective of this study was to establish whether or not these RTG indices were independently associated with incident CHD.
Methods
The Caerphilly Collaborative Heart Disease Study began in 1979 with the overall objective of examining the determinants and predictive ability of new and classical risk factors for incident CHD. During the initial recruitment phase 2512 men aged 45-59 years were examined, representing 90% of the population of men in this age group from the town of Caerphilly, South Wales, UK, and its surrounding villages (total population 40 000). Since then they have been examined at 5-year intervals. At the first re-examination between 1984 and 1988, when the men were aged 49-64 years, men of the same age who had moved into the defined geographical area were also deemed to be eligible. A total of 2398 men were recruited into the reconstructed cohort and they form the baseline population for the current study.
The general design and methods of the Caerphilly Study have been described elsewhere (Bainton et al, 1992; Sweetnam et al, 1996) . Briefly, at the survey between 1984 and 1988 the men were invited to attend an afternoon/evening clinic where a detailed medical and lifestyle history were obtained, the London School of Hygiene and Tropical Medicine (LSHTM) chest pain questionnaire (Rose et al, 1982) was administered, a full 12-lead electrocardiogram (ECG) was recorded, and height, weight and blood pressure were measured. Alcohol consumption was obtained by the use of a self-administered questionnaire checked at the clinic and converted from standard units of volume to millilitres of pure alcohol per week (Yarnell et al, 1983) . Prescribed medication has been shown previously to influence levels of haemostatic and inflammatory markers (Yarnell et al, 2000 (Yarnell et al, , 2001 and was included as a confounding variable. Only two subjects included in this analysis were taking anticoagulants during the baseline phase of this study , and were classed among those taking prescribed medication. The men were then invited to return to an early morning clinic where a blood sample was taken and a fasting blood sample was obtained from 2225 men (93%).
Follow-up procedure and definition of incident CHD
The incidence of CHD was measured up to the third re-examination of the men. In Caerphilly this took place between 1993 and 1997 with a nearly constant interval of 105 (SD ¼ 6) months after the baseline, first re-examination. All men had been flagged with the National Health Service Central Registry and all death certificates were coded to the 9th Revision of the International Classification of Diseases (ICD). Fatal CHD was defined as any death coded to ICD 410-414 inclusive. At each re-examination, the LSHTM chest pain questionnaire was re-administered and another ECG was recorded. The LSHTM chest pain questionnaire was extended to include questions about admission to hospital with severe chest pain. These, together with lists from Hospital Activity Analysis of all men admitted to local hospitals with a diagnosis of ICD 410-414, were used as a basis for a search of hospital notes for events satisfying World Health Organisation criteria 'for definite non-fatal' myocardial infarction (MI). Finally, the appearance on any follow-up ECG of major or selected moderate Q waves (Minnesota codes 1-1-any, 1-2-1 to 1-2-5 or 1-2-7) when there were no Q waves (1-1-any, 1-2-any or 1-3 any) on either the recruitment ECG or the baseline, first re-examination ECG was taken as evidence that an MI had occurred during the follow-up period.
Blood collection, storage and analysis
Blood was taken between 7.00 and 10.00 am for 91% of the men, before 7.00 am for 7% and between 10.00 and 11.00 am for 2%. The blood was collected without venous stasis into evacuated containers using a 19-gauge butterfly needle and Sarstedt monovette adapters (Leicester, UK). Various aliquots were used for measurement of different haemostatic variables.
Citrated plasma
Measurements were made during 1994, when the plasma had been stored at )70°for 6-10 years. Enzyme-linked immunosorbent assays (ELISAs) were used for measurement of VWF, d-dimer and t-PA as previously described Rumley et al, 1999) . PAI-1 activity was measured using a chromogenic assay (Chromogenix, Stockholm, Sweden) . Clottable fibrinogen was later measured by an automated Clauss assay in a Coag-A-Mate X 2 coagulometer (Organon Teknika, Cambridge, UK) with the use of a separate stored plasma sample . One-third of these samples had previously been used for another purpose, so that a total of only 1378 samples was available.
EDTA plasma
Fresh dipotassium edentate-anticoagulated samples were used to measure nephelometric fibrinogen, plasma viscosity and white cell count as described previously (Yarnell et al, 1987 (Yarnell et al, , 1991 . a 2 -Macroglobulin and a 1 -antitrypsin were measured nephelometrically with Beckman antisera kits (High Wycombe, UK). Lipid measures were made by using enzymatic assays as described previously (Bainton et al, 1992) .
Resonance-thrombography
Resonance-thrombography is a successor to the technique of thrombo-elastography (Hartert, 1981 (Hartert, , 1982 . RTG is a method for measuring the start and progression of clot formation in flowing blood, involving formation of elastic fibrin molecules and their condensation by platelets. The resonance-thrombograph consists of a cylinder suspended as a pendulum on an elastic bar. The cylinder dips into a cylindrical container heated to 37°C. The 1AE3 mm wide gap between them is filled with 0AE3-0AE4 ml of citrated whole blood up to the container's rim. All measurements were made in the Department of Haematology, Cardiff Royal Infirmary, by a dedicated technician within 7 h of collection of the samples. The action of this measuring device consists of an orbital movement of the cylinder within the container. The frequency of this electromagnetically forced movement is constant. The cylinder, by its movement, encircles a tiny orbit. In the measuring procedure the clot is subject to permanent strain by the orbital movement. Its oscillation causes a stretching of fibrin molecules and gives an assay of clot elasticity by recording a differentiating resonance effect. The instrument used was described in greater detail elsewhere (Hartert, 1982) . The RTG delivers distinguishable and characteristic types of graphs for qualitative and quantitative differences in fibrin production and similarly separate changes in platelet activity are recorded. RTG parameters are shown in Fig 1. Reaction time (r) measures the pre-phase of coagulation, f is the duration of the ascending leg of the waveform mainly determined by the growing fibrin structure -the fibrin time, AF is its amplitude. Both f and r reflect clot formation, AF reflects the final clot stiffness. The amplitude AP, representing the angle of the platelet (P) leg, is mainly determined by platelet activity. In the present study, r (min), f (min), AF (mm) and AP (mm) were measured. To simplify its measurement, the amplitude of the platelet leg (AP) was measured 300 s after maximum amplitude (AF). Due to the shape and completeness of the trace it was not always possible to measure this latter parameter, and 550 measurements could not be made for this reason.
Statistical methods
The distributions of RTG indices had a positive skew and all were transformed to logarithms. For each, this transformation produced a more nearly symmetrical Gaussian distribution and stabilized variances. Comparisons of mean values between men who developed major CHD and those who did not were made by analysis of covariance (Nie et al, 1996) .
Duplicate samples were assayed blindly by each laboratory throughout the recruitment period. Coefficients of variation were calculated for the RTG indices as follows: r ¼ 8AE3%;
Evidence of ischaemia at baseline was assessed from the chest pain questionnaire and the ECG. Three categories, namely angina, history of at least one episode of prolonged, severe chest pain and ECG ischaemia were defined as reported previously (Bainton et al, 1988) . Among the cohort of 2398 men, 736 (31%) had some evidence of ischaemia at baseline. This was similar to the prevalence found by the British Regional Heart Study (Shaper et al, 1984) for men of a similar age. Exclusion of such a large group, among whom almost half of the incident events occurred, did not seem satisfactory. Neither did the usual practice of excluding just a very small percentage (usually <5%) of men for whom there is good clinical evidence of a previous MI. Instead, we have chosen to include all men and to adjust for the presence of ischaemia at baseline by including this as a confounder in the logistic regression analyses with the occurrence, or not, of a major incident CHD event as the binary dependent variable (Yu et al, 2003) . The distributions of RTG indices were divided into equal 'thirds' and the results were presented as the relative odds of major incident CHD in each 'third', relative to a baseline 'third', which was always taken as the 33% of men with the lowest levels, with adjustment for age and other risk factors. These were referred to throughout as relative odds and where appropriate they were shown together with 95% confidence intervals (CI) estimated from the logistic regression models. Standardized relative odds were calculated as summary measures (the proportionate change in relative odds associated with standard deviation change in the RTG index).
Results
Of the total cohort of 2398 British men, 282 (11AE8% of all men) developed major new CHD events over the follow-up period of nearly 9 years. Of these 282, 132 (46AE8%) were fatal and 150 were non-fatal (53AE2%). Fasting blood samples were available from 2225 (93%) men; of these, 261 (11AE7%) developed major new CHD. Results for RTG indices were available for up to 1491 (67%) of fasting men, of whom 176 (11AE8%) developed new major CHD. Common results were available for 1470 men for r, f and AF and 920 for AP; which was unavailable for a larger number of subjects as a delay of five additional minutes was required for its measurement. Table I shows the geometric mean of RTG indices according to smoking status, social class, history of diabetes, work activity, prescribed medicine, family history of CHD and pre-existing CHD at baseline. The mean level of r was significantly different between manual and non-manual social class (P ¼ 0AE002). For AF, there were also significant differences between non-smokers, ex-smokers and current smokers (P ¼ 0AE018), between manual and non-manual social class (P ¼ 0AE001) and between subjects with and without prescribed medicine (P ¼ 0AE003). Table II shows the Pearson correlation coefficients between RTG indices and some indicators of CHD risk. Even low correlations achieved statistical significance because of the large number of subjects in the study but only correlations in excess of 0AE1 would be likely to have any biological relevance; RTG, resonance-thrombography; CHD, coronary heart disease; r, reaction time; f, fibrin formation time; AF, amplitude of fibrin leg; AP, amplitude of presenting the angle of platelet leg. +Values are geometric mean. ++Values are P-values by one-way analysis of variance. All RTG indices are logarithmically transformed. Significantly different at *0AE05, **0AE01 and ***0AE001.
r was positively associated with nephelometric and clottable fibrinogen and plasma viscosity; f was positively associated with haemoglobin, and was negatively associated with d-dimer, VWF antigen, nephelometric and clottable fibrinogen and plasma viscosity. AF was negatively associated with age, total cholesterol, d-dimer, nephelometric and clottable fibrinogen, plasma and serum viscosity, white cell count, and a1-antitrypsin. AP was negatively associated with clottable fibrinogen and haemoglobin. The strongest correlations were between AF and inflammatory and rheological markers, such as the two measurements of fibrinogen and plasma viscosity. Table III shows the mean, median and geometric mean for RTG indices in men who developed CHD, and men who did not. The mean difference was statistically significant between subjects with and without incident CHD only for AF by analysis of covariance after adjustment for age (P ¼ 0AE003); but also approached statistical significance for r (P ¼ 0AE057).
Logistic regression models were used to analyse the relation of RTG indices to the risk of incident CHD. Table IV shows the results of relative odds and 95% CI for major incident CHD events. Also shown are the standardized relative odds (SRO) -the proportionate change in relative odds associated with an increase of 1 standard deviation in the RTG indices. After adjustment for age, r was a predictor of risk of incident CHD; relative odds with increasing tertile categories, when compared with the lowest third category, were 2AE22 (95% CI, 1AE41-3AE50) and 1AE87 (95% CI, 1AE19-2AE93), respectively. Participants in the second and third tertile group showed a 122% and 
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HDL, high-density lipoprotein. *P < 0AE05, **P < 0AE01. +Values of the variable are logarithmically transformed. Abbreviations as in Table I . Table III . Mean, median and geometric mean for RTG indices in men who developed CHD, and men who did not during 9 years follow-up.
Incident CHD Free of incident CHD
SD, standard deviation; GM, geometric mean. +Values are adjusted-age mean difference (logarithmic scale) and standard error. ++The significant test between subjects with and without incident CHD by analysis of covariance; the tests were adjusted for age. Abbreviations as in Table I . 87% increase in risk in 9-year incidence of CHD, respectively. After adjusting the data additionally for age and other risk factors listed in Table IV , the relative odds were 2AE17 (95% CI, 1AE35-3AE47) and 1AE72 (95% CI, 1AE07-2AE76) respectively; men in the second and third tertile group showed a 117% and 72% increase in risk. After additional adjustment for d-dimer antigen, plasma viscosity, nephelometric fibrinogen and white cell count, men in the second and third tertile group still showed increases in risk. But the tests for trend that were summarized by SROs were not significant, either after multivariate adjustment, or after adjustment for additional haematological variables. A similar analysis was carried out for AF. After adjustment for age, relative odds with increasing tertile groups, when compared with the lowest tertile group, were 0AE80 (95% CI, 0AE55-1AE5) and 0AE56 (95% CI, 0AE37-0AE84); men in the lowest tertile group showed a 44% reduction in risk. After adjusting the data additionally for age and other risk factors, the relative odds were 0AE86 (95% CI, 0AE59-1AE27) and 0AE64 (95% CI, 0AE41-0AE98), respectively; men in the lowest tertile group showed a 36% reduction in risk. But the tests for trend were not significant, either after multivariate adjustment or after adjustment for additional haematological variables.
RTG Indices for the Prediction of Coronary Disease

Discussion
We have shown for the first time in a prospective study that two of the four RTG indices were associated with incident CHD. Men with incident CHD had a longer initial reaction time (r index; P ¼ 0AE057 on univariate analysis). The amplitude of fibrin formation (AF) was also significantly shorter in men who subsequently developed incident CHD than in men who did not (P ¼ 0AE003 on univariate analysis). The two other parameters studied did not show a significant association with incident CHD.
In general, classical CHD risk factors showed weak associations with RTG indices. Smoking, manual social class and use of prescribed medicine were associated with shorter AF index (Table I) , as were age, systolic blood pressure and cholesterol (Table II) . In contrast, haematological risk predictors including fibrinogen, plasma and serum viscosity, and fibrin d-dimer were strongly associated with shorter AF index, and longer reaction time (r index; Table II ). These findings are consistent with previous reports for fibrinogen and its degradation products (Hartert, 1981 (Hartert, , 1982 Zuckerman et al, 1981) . Increasing fibrinogen levels delay the onset of clot formation by inhibiting the rate of fibrin polymerization (Blomback et al, 1989) and produce denser fibrin clots (Lim et al, 2003) .
Adjustment for classical CHD risk factors reduced the associations of RTG indices with incident CHD to borderline statistical significance (Table IV) , while the additional adjustment for haematological risk predictors, including fibrinogen and white cell count (Danesh et al, 1998) , plasma viscosity (Danesh et al, 2000) and fibrin d-dimer (Danesh et al, 2001) reduced these associations further, especially for AF index (Table IV) . We therefore conclude that RTG indices did not add significantly to the multivariate prediction of CHD risk in the present study. Further, larger studies are required to Significantly different at *0AE05, **0AE01 and ***0AE001. Abbreviations as in Table I. determine with confidence the size of their associations with CHD risk and their use (if any) in CHD risk prediction. Our results suggest that the association of some classical CHD risk factors (e.g. smoking) (Yarnell et al, 1987) as well as some haematological variables, with CHD risk (Danesh et al, 1998 (Danesh et al, , 2000 (Danesh et al, , 2001 ) may be partly attributable to their effects on the clotting of flowing blood in vitro, and hence potentially on coronary thrombus formation in vivo. Further experimental work is required to test these hypotheses -for example the effect of smoking reduction or cessation on RTG indices.
